Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15

Marty Chaplin (), Rebecca Bresnahan, Nigel Fleeman, James Mahon, Rachel Houten, Sophie Beale, Angela Boland, Yenal Dundar, Ashley Marsden and Pinki Munot
Additional contact information
Marty Chaplin: University of Liverpool
Rebecca Bresnahan: University of Liverpool
Nigel Fleeman: University of Liverpool
James Mahon: Coldingham Analytical Services
Rachel Houten: University of Liverpool
Sophie Beale: Hare Research
Angela Boland: University of Liverpool
Yenal Dundar: University of Liverpool
Ashley Marsden: North West Medicines Information Centre
Pinki Munot: Great Ormond Hospital for Children NHS Foundation Trust

PharmacoEconomics - Open, 2023, vol. 7, issue 6, No 13, 1015-1015

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-023-00462-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:7:y:2023:i:6:d:10.1007_s41669-023-00462-7

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-023-00462-7

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().